STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Not yet recruiting
- SARS-CoV2
- COVID-19
- Ribavirin Capsules
- Favipiravir
- Ankara, Cebeci, Turkey
- +3 more
2021-04-01
Apr 1, 2021M
A
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
2021-07-08
Jul 8, 2021M
H
Recruiting
- Chronic Hepatitis C
- Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin
- Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
- Cairo, EgyptFaculty of medicine Helwan University
2021-01-03
Jan 3, 2021M
Completed
- Chronic Hepatitis C Genotype 1
- Boceprevir
- +3 more
- (no location specified)
2021-01-15
Jan 15, 2021M
S
Terminated
- Birth Defects
- +2 more
- Wilmington, North CarolinaINC Research, LLC
2020-12-10
Dec 10, 2020N
A
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-450/r/ABT-267
- +2 more
- (no location specified)
2021-07-08
Jul 8, 2021A
M
N
Completed
- HIV Infections
- Hepatitis C
- Ribavirin
- +2 more
- Los Angeles, California
- +7 more
2021-10-28
Oct 28, 2021N
Completed
- HIV Infections
- Ribavirin
- Didanosine
- Washington, District of Columbia
- +14 more
2021-10-27
Oct 27, 2021A
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
2021-07-09
Jul 9, 2021A
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
2021-07-08
Jul 8, 2021D
Completed
- Chronic Hepatics C Virus (HCV) Genotype 1
- +3 more
- TG-2349
- +2 more
- Beijing, ChinaBeijing Tsinghua Changgung Hospital
2021-02-02
Feb 2, 2021M
Completed
- Hepatitis C, Chronic
- Vaniprevir 600 mg b.i.d.
- +3 more
- (no location specified)
2021-01-15
Jan 15, 2021M
Completed
- Bone Marrow Transplant Infection
- +5 more
- Ribavirin
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2021-01-21
Jan 21, 2021T
Recruiting
- Covid19
- Interferon beta-1b
- Ribavirin
- Hong Kong, Hong KongThe University of Hong Kong, Queen Mary Hospital
2020-07-29
Jul 29, 2020M
Active, not recruiting
- BCLC Stage B Hepatocellular Carcinoma
- +10 more
- Elbasvir/Grazoprevir
- +3 more
- Houston, TexasM D Anderson Cancer Center
2022-02-25
Feb 25, 2022N
Completed
- Hepatitis C Infection
- HIV Infection
- Nitazoxanide With Pegylated Interferon And Ribavirin
- Washington, District of Columbia
- +3 more
2021-09-14
Sep 14, 2021P
Completed
- Chronic Hepatitis C Virus Infection
- P1101 + Ribavirin
- PEG-Intron + Ribavirin
- Beijing, China
- +38 more
2022-01-14
Jan 14, 2022A
M
Not yet recruiting
- COVID
- Drug Effect
- Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :
- Mansoura, Select A State Or Province, EgyptMansoura University
2020-09-01
Sep 1, 2020